Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bausch Health Companies Inc (NY: BHC ) 7.820 -0.270 (-3.34%) Official Closing Price Updated: 7:00 PM EDT, May 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,396,646 Open 8.100 Bid (Size) 7.870 (2) Ask (Size) 7.960 (1) Prev. Close 8.090 Today's Range 7.740 - 8.230 52wk Range 5.700 - 11.46 Shares Outstanding 358,808,755 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Bausch Health Companies Stock Dived by More Than 7% Today May 02, 2024 A large red number on the bottom line attracted the wrong kind of investor attention for the company. Via The Motley Fool BHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024 May 02, 2024 BHC stock results show that Bausch Health Companies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Performance YTD +0.51% +0.51% 1 Month -22.11% -22.11% 3 Month -1.26% -1.26% 6 Month +3.30% +3.30% 1 Year +32.77% +32.77% More News Read More Why Bausch Health Companies Shares Are Falling After Q1 Results May 02, 2024 Via Benzinga Bausch Health Announces First Quarter 2024 Results May 02, 2024 Via ACCESSWIRE Bausch Health to Announce First-Quarter 2024 Results on May 2 April 11, 2024 Via ACCESSWIRE Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 April 11, 2024 Via ACCESSWIRE Preview: Bausch Health Companies's Earnings February 21, 2024 Via Benzinga Salix Announces 2024 Gastrointestinal Health Scholars Program February 12, 2024 Via ACCESSWIRE Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan April 11, 2024 Via ACCESSWIRE Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals April 05, 2024 Via ACCESSWIRE Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults April 03, 2024 Via ACCESSWIRE Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations April 02, 2024 Via ACCESSWIRE Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma March 06, 2024 Via ACCESSWIRE CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China January 18, 2024 Via ACCESSWIRE Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China January 18, 2024 Via ACCESSWIRE New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure March 05, 2024 Via ACCESSWIRE Bausch Health Companies to Present at Cowen Annual Health Care Conference March 01, 2024 Via ACCESSWIRE RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know February 23, 2024 Via Benzinga Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results February 22, 2024 Via ACCESSWIRE A 'Toxic Byproduct of an Imperfect Higher Education System' — Famous Short Seller Known as 'The Assassin' Strikes Her Newest Target February 08, 2024 Via Benzinga Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis December 21, 2023 Via ACCESSWIRE Bausch Health Announces Board Refreshment February 01, 2024 Via ACCESSWIRE Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 February 01, 2024 Via ACCESSWIRE CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. January 30, 2024 Via ACCESSWIRE Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute January 07, 2024 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
